跳至主要内容
临床试验/NCT05899478
NCT05899478
已完成
不适用

Prospective, Multi-center, Randomized Controlled Study to Evaluate the Effectiveness and Safety of Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures

Suzhou Hengruihongyuan Medical Technology Co. LTD5 个研究点 分布在 1 个国家目标入组 135 人2023年6月1日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Percutaneous Intervention Via Femoral Artery
发起方
Suzhou Hengruihongyuan Medical Technology Co. LTD
入组人数
135
试验地点
5
主要终点
Rate of successful hemostasis
状态
已完成
最后更新
10个月前

概览

简要总结

The purpose of this study is to evaluate the effectiveness and safety of the suture-mediated closure system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. following endovascular peripheral arterial procedures.

详细描述

Prospective, multi-center, randomized Comparative study using the Suture-mediated Closure System produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.as an investigational device and the Perclose® ProGlide Suture-Mediated Closure System as a comparator. After going through the confirmation of inclusion/exclusion criteria with signed subjects, they will have a procedure either of the two devices. The subjects should follow designated physician's instructions accurately during the clinical trial period. There are about 4 times evaluations Including screening.

注册库
clinicaltrials.gov
开始日期
2023年6月1日
结束日期
2024年4月1日
最后更新
10个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Suzhou Hengruihongyuan Medical Technology Co. LTD
责任方
Sponsor

入排标准

入选标准

  • Patients who can use 5Fr to 21Fr sheath for common femoral artery puncture for interventional catheterization or therapy
  • Informed consent signed by the patient or legal representative

排除标准

  • Pregnancy or lactation period;
  • Diameter of femoral artery site for puncture\< 5mm;
  • Have participated in another clinical study during the same period;
  • Known allergy to any device component, and/or contraindications of contrast agents and anticoagulants;
  • Vascular injury at the site of the approach;
  • Groin infection;
  • Morbid obesity (BMI≥40kg / ㎡);
  • Ultrasonographic assessment of the entire common femoral artery wall showed that the common femoral artery stenosis was ≥ 50%;
  • There are femoral aneurysms, arteriovenous fistulas or pseudoaneurysms in the common femoral artery;
  • Clamp vessel closures were used at the previous ipsilateral artery approach;

结局指标

主要结局

Rate of successful hemostasis

时间窗: 10 minutes

Calculation method: Patients with successful hemostasis / total cases of subjects in the same group x 100%. Definition of successful hemostasis: Within 10 minutes after completion of the suturing procedure, there is no bleeding or hematoma at the puncture site, and no other intervention or surgical treatment is required.

次要结局

  • Evaluation of Withdrawal performance of the device(Approximately 15-minutes after device removal)
  • Operation time(Approximately 15-minutes after device removal)
  • Technical success rate(Approximately 15-minutes after device removal)
  • Evaluation of Performance of tightening knot of the device(Approximately 15-minutes after device removal)
  • Hemostasis time(Approximately 15-minutes after compression)
  • Evaluation of Compatibility with guidewires of the device(Approximately 15-minutes after device removal)
  • Evaluation of Pushing performance of the device(Approximately 15-minutes after device removal)

研究点 (5)

Loading locations...

相似试验